Key facts
- Surgify’s last known valuation is $7.7M (Jan 2021).
- It has raised $13.3M; the latest was Later Stage VC ($7.9M) in May 2025.
- Notable investors include European Innovation Council, Innovestor, Wave Ventures, Tekes, Aalto Start-Up Center — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Surgify
- ·The full record, as it builds
Funding rounds
No funding rounds for Surgify are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Surgify
Developer of a bone surgery technology designed to protect proximal soft structures and prevent associated complications. The company's technology assists healthcare providers to avoid bleeding, infections and nerve injuries which can be complications for the patient, enabling surgeons to reduce patient suffering by protecting the vital structures and improving patients' quality of life.
- Sector
- Healthcare
- HQ
- Espoo, Finland
- Founded
- 2016
- Employees
- 21
- Website
- surgifymedical.com/
- Ownership
- Privately Held (backing)
Surgify doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Surgify shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Surgify in its N-PORT filings yet. We sweep new filings monthly.